Home > Medical Reference > Complementary Medicine

Leukemia


Leukemia is a type of cancer in which the body produces large numbers of abnormal (usually white) blood cells. Approximately 28,500 new cases of leukemia are diagnosed each year. There are several types of leukemia, grouped as either acute (the diseases progresses rapidly) or chronic (the diseases progresses slowly). The most common leukemias are:


Signs and Symptoms

Leukemia is often accompanied by the following signs and symptoms:


What Causes It?

Most causes of leukemia are not known. However, the disease has been linked to exposure to large amounts of high-energy radiation (from nuclear bombs), occupational exposure to the chemical benzene, viral infections, and chemicals from cigarettes.


Who's Most At Risk?

Leukemia is linked to the following risk factors:


What to Expect at Your Provider's Office

If you or your child is experiencing symptoms associated with leukemia, see your health care provider. He or she can help make a diagnosis and help you determine which treatment or combination of therapies will work best.

Your provider will do a physical examination, checking for swelling in the liver, the spleen, and the lymph nodes, and will order certain laboratory tests. The bone marrow is examined for leukemia cells or to determine the type of leukemia. A lumbar puncture ("spinal tap") checks for leukemia cells in the fluid around the brain and spinal cord, and chest x-rays can reveal signs of the disease in the chest.


Treatment Options

Prevention

Some leukemias can be prevented by avoiding exposure to benzene, nicotine, or radiation.

Treatment Plan

Leukemia is an extremely complex disease. Treatment depends on the type of leukemia, certain features of the leukemic cells, the extent of the disease, and whether the leukemia has been treated before. Whenever possible, a patient with leukemia should be treated at a medical center that specializes in this disease.

Drug Therapies

Some of the drug therapies used to treat leukemia include the following:

Surgical and Other Procedures

Surgeries may include the following:

Complementary and Alternative Therapies

A comprehensive treatment plan for leukemia may include a range of complementary and alternative therapies.

Nutrition and Supplements

Following these nutritional tips may help reduce symptoms:

You may address nutritional deficiencies with the following supplements:

Herbs

Herbs are generally a safe way to strengthen and tone the body's systems. As with any therapy, you should work with your health care provider to get your problem diagnosed before starting any treatment. You may use herbs as dried extracts (capsules, powders, teas), glycerites (glycerine extracts), or tinctures (alcohol extracts). Unless otherwise indicated, you should make teas with 1 tsp. herb per cup of hot water. Steep covered 5 - 10 minutes for leaf or flowers, and 10 - 20 minutes for roots. Drink 2 - 4 cups per day. You may use tinctures alone or in combination as noted.

Homeopathy

An experienced homeopath can prescribe a regimen for treating leukemia that is designed especially for you. Acute remedies may be useful for relief of symptoms associated with complications.

Homeopathy may help reduce symptoms and strengthen overall constitution and may help decrease the side effects of chemotherapy.

Acupuncture

Acupuncture may alleviate symptoms. Acupuncture may help to enhance immune function, normalize digestion, and address disease conditions. For many patients and physicians, acupuncture has become one of the most widely used alternative interventions in cancer therapy support.


Prognosis/Possible Complications

Repeated infections complicate most cases of leukemia. Kidney failure or impaired function and a decreasing number of neutrophils (a type of white blood cell) are also common complications. Treatments for leukemia can have serious side effects.

The prognosis for people with leukemia varies by the type of leukemia. ALL patients have the best prognosis, with a 35 - 45% 5-year survival rate and a 40%long-term survival rate.


Following Up

Patients with leukemia undergo extensive follow-up care, including daily exams to check for infections and bleeding, weekly bone marrow biopsies after chemotherapy has begun, post-remission chemotherapy, treatment for central nervous system conditions, and monitoring of urinary function.


Supporting Research

Benchimol EI, Mack DR. Probiotics in relapsing and chronic diarrhea. J Pediatr Hematol Oncol . 2004;26(8):515-7.

Boros LG, Nichelatti M, Schoenfeld Y. Fermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases. Ann N Y Acad Sci . 2005;1051:529-42.

Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea--a review. J Am Coll Nutr . 2006;25(2):79-99.

Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999;69(6):1086-1107.

Cheng TO. Can green tea protect against not only sunburn but also melanoma? Chin Med J (Engl). 2006;119(12):1056.

Cunningham FG, et al. Williams Obstetrics . 19th ed. Norwalk, Conn: Appleton & Lange; 1993:1270-1272.

Das M, Sur P, Gomes A, Vedasiromoni JR, Ganguly DK. Inhibition of tumor growth and inflammation by consumption of tea. Phytother Res . 2002;16 Suppl 1:S40-4.

DeVita VT Jr, et al. Cancer: Principles and Practice of Oncology . 5th ed. Philadelphia, Pa: Lippincott-Raven; 1997:2293-2338.

Dorchies OM, Wagner S, Vuadens O, et al. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol . 2006;290(2):C616-25.

Eschenauer G, Sweet BV. Pharmacology and therapeutic uses of theanine. Am J Health Syst Pharm . 2006;63(1):26, 28-30.

Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine . 14th ed. New York, NY: McGraw-Hill; 1998:685-694.

Holleb AI, et al. American Cancer Society Textbook of Clinical Oncology . Atlanta, Ga. American Cancer Society; 1991: 410-432.

Hollender A, Bjoro T, Otto Karlsen K, et al. Vitamin D deficiency in patients operated on for gastric lymphoma. Scand J Gastroenterol . 2006;41(6):673-81.

JAMA Patient Page. How much vitamin C do you need? JAMA. 1999;281(15):1460.

Jiang J, Slivova V, Sliva D. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol . 2006;29(3):695-703.

Johnston CS. Recommendations for vitamin C intake. JAMA. 1999;282(22):2118-2119.

Jong, S. C. and Birmingham, J. M. Medicinal benefits of the mushroom Ganoderma. Adv.Appl Microbiol . 1992;37:101-134.

Kelemen LE, Cerhan JR, Lim U, et al. Vegetables, fruit, and antioxidant-related nutrients and risk of non-Hodgkin lymphoma: a National Cancer Institute-Surveillance, Epidemiology, and End Results population-based case-control study. Am J Clin Nutr . 2006;83(6):1401-10.

Kelly WN. Textbook of Internal Medicine . Vol 1. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1997: 1370-1381.

Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res . 2006;20(5):424-5.

Laviano A, Muscaritoli M, Rossi-Fanelli F. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia: a Cancer and Leukemia Group B study. Cancer . 2005;103(3):651-2.

Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y. Criteria and recommendations for vitamin C intake. JAMA. 1999;281(15):1415-1453.

McCarty MF, Block KI. Toward a core nutraceutical program for cancer management. Integr Cancer Ther . 2006;5(2):150-71.

McCunney RJ. Hodgkin's disease, work, and the environment. J Occupational Environ Med . 1999; 41(1).

Moss RW. Alternative pharmacological and biological treatments for cancer: Ten promising approaches. J Naturopathic Med . 1996; 6(1):23-32.

Polesel J, Talamini R, Montella M, et al. Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol . 2006;17(4):713-8.

Wan XS, Ware JH, Zhou Z, Donahe JJ, et al. Protection against radiation-induced oxidative stress in cultured human epithelial cells by treatment with antioxidant agents. Int J Radiat Oncol Biol Phys . 2006;64(5):1475-81.

Wang HK. The therapeutic potential of flavonoids. Expert Opin Investig Drugs . 2000;9(9):2103-19.

Wittes RE. Manual of Oncologic Therapeutics . Philadelphia, Pa: Lippincott; 1990: 345-366.

Woodley M. Manual of Medical Therapeutics . 27th ed. Boston, Mass: Little, Brown; 1992:360-361.


A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com